ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2017

Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents.

Walter Reinisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.